genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
Eli Lilly
Lilly Making First Milestone Payment in $1.9B Collaboration with AC Immune
News
Microbiome Hungry for the Right Fiber
Neuroscience
This Receptor Actually Leaves a Sour Taste in One’s Mouth
News
A Denisovan as Pretty as an Epigenetic Picture
News
Ginkgo to Expand Applications of Cell Programming Platform with $290M Series…
Insights
Tech Exclusives
8 Companion Diagnostic Developers Making a Mark
Tech Exclusives
CRISPR-Chip Launched as “Genome Sensor”
Bioprocessing
Controlling Impurities in Cell Culture Media
Insights
10 Takeover Targets to Watch This Fall
Tech Exclusives
Going Viral: The Next Generation of AAV Vectors
A-Lists
Insights
10 Takeover Targets to Watch This Fall
Insights
What the Top 10 Biopharma CEOs Are Making
Insights
Top 10 Companies Leveraging Gene Editing in 2019
Insights
Top 10 Young Companies in the Money, January–July 2019
August 2019 Vol. 39 No. 8
Top 10 Biopharma IPOs of January–June 2019
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Eli Lilly
Lilly Making First Milestone Payment in $1.9B Collaboration with AC Immune
News
Microbiome Hungry for the Right Fiber
Tech Exclusives
8 Companion Diagnostic Developers Making a Mark
News
A Denisovan as Pretty as an Epigenetic Picture
Magazine
Tech Exclusives
Going Viral: The Next Generation of AAV Vectors
Tech Exclusives
Looking Into a Crystal Ball
Tech Exclusives
Liquid Biopsies Intensify Surveillance of ctDNA
Tech Exclusives
Drug–Drug Interaction Studies Look Beyond CYP Activity
Tech Exclusives
3D Bioprinting Makes the Imitation Matrix Real
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
eBooks
Breakthroughs in Immunotherapy
Upcoming Webinars
Pancreatic Cancer Therapeutic Target Visualized Using In Situ Hybridization
Upcoming Webinars
Bring Greater Efficiency to Your Biobank Lab
Upcoming Webinars
Reliable Single Cell Outgrowth: Dark Art or Science?
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Rare and Neglected Diseases
Rare and Neglected Diseases
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Rare and Neglected Diseases
Passage Bio Licenses Gene Therapy Candidate for CMT2A from Penn, Days after Raising $110M
Rare and Neglected Diseases
Sumitomo Dainippon Commits $3B toward Alliance with Roivant
Rare and Neglected Diseases
Acer Therapeutics Axes 60% of Workforce after FDA Rebuff
Rare and Neglected Diseases
Amicus, Thermo Fisher’s Brammer Bio Partner on Gene Therapy Manufacturing
Rare and Neglected Diseases
Vertex Grows Gene Editing Presence, Acquiring Exonics and Expanding CRISPR Therapeutics Collaboration
Rare and Neglected Diseases
Orchard Therapeutics Licenses MPS-I Gene Therapy from SR-TIGET
Rare and Neglected Diseases
Gilead Sciences Launches Up-to-$2B Kidney Disease Partnership with Goldfinch Bio
Rare and Neglected Diseases
Pfizer to Acquire Therachon for Up to $810M, Expanding Rare Disease...
Rare and Neglected Diseases
Takeda Inks Licensing Option Agreement with Gene Editing Platform Developer Emendo
Rare and Neglected Diseases
Alexion Inks Collaborations Totaling $1.3B+ with Affibody, Zealand
Rare and Neglected Diseases
Pfizer Gains Option to Buy Rare Disease Gene Therapy Developer Vivet...
Rare and Neglected Diseases
Roche-Licensed Rare Disease Drug at Center of Ipsen’s Up-to-$1.3B Clementia Acquisition
Rare and Neglected Diseases
Wilson among Co-Founders of Gene Therapy Developer Launched with $115.5M
Rare and Neglected Diseases
Sangamo Shares Plunge after Interim Results for MPS Candidates Fall Short...
Rare and Neglected Diseases
Licensing Deal Moves Merck KGaA, Vertex Further into Gene Editing-Based Drug...
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
